| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Schmidt CJ |
Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphet... |
J Pharmacol Exp Ther |
1987 |
| Nash JF Jr, Meltzer HY, G... |
Elevation of serum prolactin and corticosterone concentrations in the ... |
J Pharmacol Exp Ther |
1988 |
| Sprouse JS, Bradberry CW,... |
MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal... |
Eur J Pharmacol |
1989 |
| Azmitia EC, Murphy RB, Wh... |
MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for ... |
Brain Res |
1990 |
| Callaway CW, Wing LL, Gey... |
Serotonin release contributes to the locomotor stimulant effects of 3,... |
J Pharmacol Exp Ther |
1990 |
| Fitzgerald JL, Reid JJ |
Effects of methylenedioxymethamphetamine on the release of monoamines ... |
Eur J Pharmacol |
1990 |
| McKenna DJ, Guan XM, Shul... |
3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential eff... |
Pharmacol Biochem Be... |
1991 |
| Callaway CW, Johnson MP, ... |
Amphetamine derivatives induce locomotor hyperactivity by acting as in... |
Psychopharmacology (... |
1991 |
| Dragunow M, Logan B, Lave... |
3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat bas... |
Eur J Pharmacol |
1991 |
| Nash JF, Brodkin J |
Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dop... |
J Pharmacol Exp Ther |
1991 |
| Pan HS, Wang RY |
MDMA: further evidence that its action in the medial prefrontal cortex... |
Brain Res |
1991 |
| Berger UV, Gu XF, Azmitia... |
The substituted amphetamines 3,4-methylenedioxymethamphetamine, metham... |
Eur J Pharmacol |
1992 |
| Callaway CW, Geyer MA |
Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus ... |
Eur J Pharmacol |
1992 |
| Kehne JH, McCloskey TC, T... |
Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (... |
J Pharmacol Exp Ther |
1992 |
| Gu XF, Azmitia EC |
Integrative transporter-mediated release from cytoplasmic and vesicula... |
Eur J Pharmacol |
1993 |
| Hashimoto K, Maeda H, Hir... |
Drug effects on distribution of [3H]3,4-methylenedioxymethamphetamine ... |
Eur J Pharmacol |
1993 |
| Krebs KM, Geyer MA |
Behavioral characterization of alpha-ethyltryptamine, a tryptamine der... |
Psychopharmacology (... |
1993 |
| Rempel NL, Callaway CW, G... |
Serotonin1B receptor activation mimics behavioral effects of presynapt... |
Neuropsychopharmacol... |
1993 |
| Shiue CY, Shiue GG, Rysav... |
Fluorine-18 and carbon-11 labeled amphetamine analogs--synthesis, dist... |
Nucl Med Biol |
1993 |
| Leonardi ETK, Azmitia EC |
MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with f... |
Neuropsychopharmacol... |
1994 |
| Marona-Lewicka D, Nichols... |
Behavioral effects of the highly selective serotonin releasing agent 5... |
Eur J Pharmacol |
1994 |
| Sprague JE, Nichols DE |
The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-meth... |
J Pharmacol Exp Ther |
1995 |
| Wichems CH, Hollingsworth... |
Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDM... |
Brain Res |
1995 |
| Gudelsky GA, Nash JF |
Carrier-mediated release of serotonin by 3,4-methylenedioxymethampheta... |
J Neurochem |
1996 |
| Malberg JE, Sabol KE, Sei... |
Co-administration of MDMA with drugs that protect against MDMA neuroto... |
J Pharmacol Exp Ther |
1996 |
| Obradovic T, Imel KM, Whi... |
Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... |
Neuroscience |
1996 |
| Obradovic T, Imel KM, Whi... |
Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... |
Neuroscience |
1996 |
| Kramer HK, Poblete JC, Az... |
Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetam... |
Neuropsychopharmacol... |
1997 |
| Koch S, Galloway MP |
MDMA induced dopamine release in vivo: role of endogenous serotonin |
J Neural Transm |
1997 |
| Aguirre N, Ballaz S, Lash... |
MDMA ('Ecstasy') enhances 5-HT1A receptor density and 8-OH-DPAT-induce... |
Eur J Pharmacol |
1998 |
| Byard RW, Gilbert J, Jame... |
Amphetamine derivative fatalities in South Australia--is 'Ecstasy' the... |
Am J Forensic Med Pa... |
1998 |
| Windhaber J, Maierhofer D... |
Panic disorder induced by large doses of 3,4-methylenedioxymethampheta... |
J Clin Psychopharmac... |
1998 |
| Kramer HK, Poblete JC, Az... |
Characterization of the translocation of protein kinase C (PKC) by 3,4... |
Neuropsychopharmacol... |
1998 |
| Shankaran M, Yamamoto BK,... |
Involvement of the serotonin transporter in the formation of hydroxyl ... |
Eur J Pharmacol |
1999 |
| Virden TB, Baker LE |
Disruption of the discriminative stimulus effects of S(+)-3,4-methylen... |
Behavioural Pharmaco... |
1999 |
| Mortensen OV, Kristensen ... |
Molecular cloning, expression and characterization of a bovine seroton... |
Brain Res Mol Brain ... |
1999 |
| Kalia M, O'Callaghan JP, ... |
Comparative study of fluoxetine, sibutramine, sertraline and dexfenflu... |
Brain Res |
2000 |
| Sanchez V, Camarero J, Es... |
The mechanisms involved in the long-lasting neuroprotective effect of ... |
Br J Pharmacol |
2001 |
| O'Shea E, Esteban B, Cama... |
Effect of GBR 12909 and fluoxetine on the acute and long term changes ... |
Neuropharmacology |
2001 |
| Mamamoorthy Y, Tyndale R,... |
Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic a... |
Pharmacogenetics |
2001 |
| Mortensen OV, Kristensen ... |
Species-scanning mutagenesis of the serotonin transporter reveals resi... |
J Neurochem |
2001 |
| Ramamoorthy Y, Tyndale RF... |
Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic a... |
Pharmacogenetics |
2001 |
| Mechan AO, Esteban B, O'S... |
The pharmacology of the acute hyperthermic response that follows admin... |
Br J Pharmacol |
2002 |
| Whitworth TL, Herndon LC,... |
Psychostimulants differentially regulate serotonin transporter express... |
J Neurosci |
2002 |
| Ramamoorthy Y, Yu A, Suh ... |
Reduced (+/-)-3,4-methylenedioxymethamphetamine ('Ecstasy') metabolism... |
Biochem Pharmacol |
2002 |
| Fantegrossi WE, Godlewski... |
Pharmacological characterization of the effects of 3,4-methylenedioxym... |
Psychopharmacology (... |
2003 |
| Orio L, O'Shea E, Sanchez... |
3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels a... |
J Neurochem |
2004 |
| Meredith EJ, Holder MJ, C... |
The serotonin transporter (SLC6A4) is present in B-cell clones of dive... |
FASEB J |
2005 |
| Meredith EJ, Holder MJ, C... |
The serotonin transporter (SLC6A4) is present in B-cell clones of dive... |
FASEB J |
2005 |
| Escobedo I, Peraile I, Or... |
Evidence for a role of Hsp70 in the neuroprotection induced by heat sh... |
J Neurochem |
2007 |
| Benzer TI, Nejad SH, Floo... |
Case records of the Massachusetts General Hospital Case 40-2013A 36-ye... |
N Engl J Med |
2013 |
